Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
2.330
-0.070 (-2.92%)
At close: Jul 24, 2026, 4:00 PM EDT
2.360
+0.030 (1.29%)
After-hours: Jul 24, 2026, 7:34 PM EDT
Ovid Therapeutics Market Cap
Ovid Therapeutics has a market cap or net worth of $434.87 million as of July 24, 2026. Its market cap has increased by 773.24% in one year.
Market Cap
434.87M
Enterprise Value
282.34M
1-Year Change
773.24%
Ranking
Category
Stock Price
$2.33
ChartMarket Cap Chart
Since May 5, 2017, Ovid Therapeutics's market cap has increased from $301.40M to $434.87M, an increase of 44.28%. That is a compound annual growth rate of 4.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 434.90M | 274.59% |
| Dec 31, 2025 | 116.10M | 75.11% |
| Dec 31, 2024 | 66.30M | -70.87% |
| Dec 29, 2023 | 227.60M | 73.61% |
| Dec 30, 2022 | 131.10M | -40.03% |
| Dec 31, 2021 | 218.60M | 49.22% |
| Dec 31, 2020 | 146.50M | -26.16% |
| Dec 31, 2019 | 198.40M | 232.33% |
| Dec 31, 2018 | 59.70M | -75.41% |
| Dec 29, 2017 | 242.80M | -19.44% |
| May 5, 2017 | 301.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Valneva SE | 463.62M |
| ProKidney | 462.15M |
| Kyverna Therapeutics | 449.88M |
| Cabaletta Bio | 448.40M |
| Prothena Corporation | 441.86M |
| Ocugen | 436.69M |
| Sagimet Biosciences | 435.35M |
| Editas Medicine | 426.62M |